209例肺癌患者抗菌药物应用分析

目的调查解放军总医院第一附属医院肺癌患者抗菌药物的临床使用情况,为临床合理用药提供帮助。方法回顾性调查该院2009年1～12月209例肺癌患者的病例资料,对抗菌药物使用的各项数据进行综合分析。结果 209例患者抗菌药物使用率为39.71%。抗菌药物使用以单一用药为主,占49.40%。抗菌药物以β-内酰胺类为主,其中头孢菌素使用频次最高。抗菌药物费用占药品总费用的7.17%,日均费用差异较大。结论抗菌药物使用总体较合理,存在问题主要是病原菌检查及药敏试验比率较低,日均费用较低的品种未得到广泛使用。

Analysis of Use of Antibacterial Drugs among 209 Lung Cancer Patients

Objective To investigate the clinical use of antibacterial drugs among patients with lung cancer Methods Data of 209 cases of lung cancer between January 2009 and December 2011 were retrospectively collected. The use of antibacterial drugs was comprehensively analyzed. Results Among the 209 patients,39.71% used antibacterial drugs, and 49.40% received monotherapy. The use of β-lactam was dominationg and cephalosporin was used most frequently. The antibacterial consumption sum made up 7.17% of the total drug fees and DDC varied significantly. Conclusion The overall use of antibacterial is rational. Existing problems include the low the testing rate of pathogens and drug susceptibility and the limited use of low DDC varieties.